148 related items for PubMed ID: 24557606
1. Ocular complications in children with nephrotic syndrome on long term oral steroids.
Gaur S, Joseph M, Nityanandam S, Subramanian S, Koshy AS, Vasudevan A, Phadke KD, Iyengar A.
Indian J Pediatr; 2014 Jul; 81(7):680-3. PubMed ID: 24557606
[Abstract] [Full Text] [Related]
2. Incidence and predictive risk factors for ophthalmological complications in children with nephrotic syndrome receiving long-term oral corticosteroids: a cohort study.
Hariharan R, Krishnamurthy S, Kaliaperumal S, Karunakar P, Deepthi B.
Paediatr Int Child Health; 2021 Aug; 41(3):199-205. PubMed ID: 34711131
[Abstract] [Full Text] [Related]
3. Cataract and ocular hypertension in children on inhaled corticosteroid therapy.
Behbehani AH, Owayed AF, Hijazi ZM, Eslah EA, Al-Jazzaf AM.
J Pediatr Ophthalmol Strabismus; 2005 Aug; 42(1):23-7. PubMed ID: 15724895
[Abstract] [Full Text] [Related]
4. Outcome of Ocular Steroid Hypertensive Response in Children.
Kaur S, Dhiman I, Kaushik S, Raj S, Pandav SS.
J Glaucoma; 2016 Apr; 25(4):343-7. PubMed ID: 25651206
[Abstract] [Full Text] [Related]
5. Ocular complications of paediatric patients with nephrotic syndrome.
Ng JS, Wong W, Law RW, Hui J, Wong EN, Lam DS.
Clin Exp Ophthalmol; 2001 Aug; 29(4):239-43. PubMed ID: 11545423
[Abstract] [Full Text] [Related]
6. [Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome].
Zhao Y, Su BG, Xiao HJ, Zhang HW, Liu XY, Wang F, Ding J.
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct 18; 49(5):794-797. PubMed ID: 29045958
[Abstract] [Full Text] [Related]
7. Development of posterior subcapsular cataracts in asthmatic children.
Bhagat RG, Chai H.
Pediatrics; 1984 May 18; 73(5):626-30. PubMed ID: 6718118
[Abstract] [Full Text] [Related]
8. Steroid induced ocular complications in idiopathic nephrotic syndrome: a cross sectional single center study.
Zulfiqar Z, Lanewala F, Khatri S, Bajeer I, Aziz M, Hashmi S.
J Pak Med Assoc; 2024 Feb 18; 74(2):315-319. PubMed ID: 38419233
[Abstract] [Full Text] [Related]
9. Ocular findings in Japanese children with nephrotic syndrome receiving prolonged corticosteroid therapy.
Hayasaka Y, Hayasaka S, Matsukura H.
Ophthalmologica; 2006 Feb 18; 220(3):181-5. PubMed ID: 16679793
[Abstract] [Full Text] [Related]
10. Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study.
Prasad D, Poddar U, Kanaujia V, Yachha SK, Srivastava A.
J Glaucoma; 2019 Oct 18; 28(10):929-933. PubMed ID: 31453897
[Abstract] [Full Text] [Related]
11. Risk of ocular hypertension in children treated with systemic glucocorticoid.
Krag S, Larsen D, Albertsen BK, Glerup M.
Acta Ophthalmol; 2021 Dec 18; 99(8):e1430-e1434. PubMed ID: 33629533
[Abstract] [Full Text] [Related]
12. Early and frequent development of ocular hypertension in children with nephrotic syndrome.
Kawaguchi E, Ishikura K, Hamada R, Nagaoka Y, Morikawa Y, Sakai T, Hamasaki Y, Hataya H, Noda E, Miura M, Ando T, Honda M.
Pediatr Nephrol; 2014 Nov 18; 29(11):2165-71. PubMed ID: 24859790
[Abstract] [Full Text] [Related]
13. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
14. Ocular implications of long-term prednisone therapy in children.
Kaye LD, Kalenak JW, Price RL, Cunningham R.
J Pediatr Ophthalmol Strabismus; 1993 May 23; 30(3):142-4. PubMed ID: 8350220
[Abstract] [Full Text] [Related]
15. Posterior subcapsular cataract in nephrotic children receiving steroid therapy.
Kobayashi Y, Akaishi K, Nishio T, Kobayashi Y, Kimura Y.
Am J Dis Child; 1974 Nov 23; 128(5):671-3. PubMed ID: 4420227
[No Abstract] [Full Text] [Related]
16. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Raman V, Krishnamurthy S, Harichandrakumar KT.
Pediatr Nephrol; 2016 Apr 23; 31(4):595-604. PubMed ID: 26759000
[Abstract] [Full Text] [Related]
17. Corticosteroid-induced cataracts in idiopathic nephrotic syndrome.
Brocklebank JT, Harcourt RB, Meadow SR.
Arch Dis Child; 1982 Jan 23; 57(1):30-4. PubMed ID: 7065690
[Abstract] [Full Text] [Related]
18. Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease.
Tripathi RC, Kipp MA, Tripathi BJ, Kirschner BS, Borisuth NS, Shevell SK, Ernest JT.
Lens Eye Toxic Res; 1992 Jan 23; 9(3-4):469-82. PubMed ID: 1301798
[Abstract] [Full Text] [Related]
19. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
Health Technol Assess; 2019 May 23; 23(26):1-108. PubMed ID: 31156083
[Abstract] [Full Text] [Related]
20. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr 23; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
